For SLE patients who had been on immunosuppressants, NOD2 expression was significantly decreased in mDCs (Figure 1E, p = 0.016) and pDCs (Figure 1F, p = 0.018) of patients with active disease (Group 3) when compared to HCs. Here, NOD2 is linked to systemic lupus erythematosus.